Clinical trial
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
NCT05364021
Study timeline
Study start (actual)2022-03-03Date precision: day
Registry last updated2024-11-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Dravet Syndromeunresolved
Lennox Gastaut Syndromeunresolved
Interventions
Sponsors & collaborators
Longboard Pharmaceuticalslead sponsor
Mapped research locations
OrlandoFlorida, United States2AustinTexas, United States2New YorkNew York, United States1ChicagoIllinois, United States1St LouisMissouri, United States1MiamiFlorida, United States1San FranciscoCalifornia, United States1ClevelandOhio, United States1TampaFlorida, United States1PortlandOregon, United States1Salt Lake CityUtah, United States1RochesterMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05364021 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.